US6311031081 - Common Stock

**NDAQ** gets a fundamental rating of **4** out of 10. The analysis compared the fundamentals against 219 industry peers in the **Capital Markets** industry. While **NDAQ** is still in line with the averages on profitability rating, there are concerns on its financial health. **NDAQ** is valied quite expensively at the moment, while it does show a decent growth rate.

In the past year **NDAQ** was profitable.

In the past 5 years **NDAQ** has always been profitable.

Each year in the past 5 years **NDAQ** had a positive operating cash flow.

With a **Return On Assets** value of **3.13%**, **NDAQ** perfoms like the industry average, outperforming **53.49%** of the companies in the same industry.

The **Return On Equity** of **NDAQ** (**8.69%**) is comparable to the rest of the industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 3.13% | ||

ROE | 8.69% | ||

ROIC | 6.14% |

ROA(3y)4.86%

ROA(5y)5.06%

ROE(3y)15.55%

ROE(5y)14.97%

ROIC(3y)8.45%

ROIC(5y)8.29%

With a **Profit Margin** value of **14.43%**, **NDAQ** perfoms like the industry average, outperforming **47.44%** of the companies in the same industry.

Looking at the **Gross Margin**, with a value of **66.01%**, **NDAQ** is in the better half of the industry, outperforming **65.12%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 28.35% | ||

PM (TTM) | 14.43% | ||

GM | 66.01% |

OM growth 3Y7.45%

OM growth 5Y3.96%

PM growth 3Y1.74%

PM growth 5Y10.28%

GM growth 3Y7.58%

GM growth 5Y1.69%

Compared to 5 years ago, **NDAQ** has more shares outstanding

The debt/assets ratio for **NDAQ** is higher compared to a year ago.

With a decent **Altman-Z score** value of **2.08**, **NDAQ** is doing good in the industry, outperforming **72.09%** of the companies in the same industry.

Looking at the **Debt to FCF ratio**, with a value of **6.37**, **NDAQ** is in the better half of the industry, outperforming **61.40%** of the companies in the same industry.

A Debt/Equity ratio of **0.90** indicates that **NDAQ** is somewhat dependend on debt financing.

Looking at the **Debt to Equity ratio**, with a value of **0.90**, **NDAQ** is in line with its industry, outperforming **54.42%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.9 | ||

Debt/FCF | 6.37 | ||

Altman-Z | 2.08 |

ROIC/WACCN/A

WACCN/A

A Quick Ratio of **0.94** indicates that **NDAQ** may have some problems paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 0.94 | ||

Quick Ratio | 0.94 |

Measured over the past years, **NDAQ** shows a quite strong growth in **Earnings Per Share**. The EPS has been growing by **11.94%** on average per year.

The **Revenue** has been growing slightly by **7.52%** in the past year.

Measured over the past years, **NDAQ** shows a small growth in **Revenue**. The Revenue has been growing by **7.23%** on average per year.

EPS 1Y (TTM)1.1%

EPS 3Y11.23%

EPS 5Y11.94%

EPS Q2Q%-2.82%

Revenue 1Y (TTM)7.52%

Revenue growth 3Y2.52%

Revenue growth 5Y7.23%

Sales Q2Q%25.3%

Based on estimates for the next years, **NDAQ** will show a quite strong growth in **Earnings Per Share**. The EPS will grow by **8.65%** on average per year.

Based on estimates for the next years, **NDAQ** will show a quite strong growth in **Revenue**. The Revenue will grow by **9.41%** on average per year.

EPS Next Y-0.65%

EPS Next 2Y5.8%

EPS Next 3Y8.14%

EPS Next 5Y8.65%

Revenue Next Year21.65%

Revenue Next 2Y14.11%

Revenue Next 3Y11.97%

Revenue Next 5Y9.41%

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

Based on the **Price/Earnings** ratio of **26.65**, the valuation of **NDAQ** can be described as expensive.

Based on the **Price/Earnings** ratio, **NDAQ** is valued a bit more expensive than 68.37% of the companies in the same industry.

Based on the **Price/Forward Earnings** ratio of **23.14**, the valuation of **NDAQ** can be described as rather expensive.

Based on the **Price/Forward Earnings** ratio, **NDAQ** is valued a bit more expensive than the industry average as 65.58% of the companies are valued more cheaply.

When comparing the **Price/Forward Earnings** ratio of **NDAQ** to the average of the S&P500 Index (**22.09**), we can say **NDAQ** is valued inline with the index average.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 26.65 | ||

Fwd PE | 23.14 |

Based on the **Enterprise Value to EBITDA** ratio, **NDAQ** is valued a bit cheaper than 66.98% of the companies in the same industry.

The rest of the industry has a similar **Price/Free Cash Flow** ratio as **NDAQ**.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 27.47 | ||

EV/EBITDA | 21.5 |

PEG (NY)N/A

PEG (5Y)2.23

EPS Next 2Y5.8%

EPS Next 3Y8.14%

Compared to an average S&P500 **Dividend Yield** of **2.26**, **NDAQ**'s dividend is way lower than the S&P500 average.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.32% |

The dividend of **NDAQ** is nicely growing with an annual growth rate of **8.05%**!

Dividend Growth(5Y)8.05%

Div Incr Years11

Div Non Decr Years11

The dividend of **NDAQ** is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.

DP52.8%

EPS Next 2Y5.8%

EPS Next 3Y8.14%

**NASDAQ INC**

NASDAQ:NDAQ (9/16/2024, 8:00:02 PM)

After market: 73.3 0 (0%)**73.3**

**+0.3 (+0.41%) **

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryCapital Markets

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap42.22B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.32% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 26.65 | ||

Fwd PE | 23.14 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)2.23

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 3.13% | ||

ROE | 8.69% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 28.35% | ||

PM (TTM) | 14.43% | ||

GM | 66.01% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.22

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.9 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 0.94 | ||

Quick Ratio | 0.94 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)1.1%

EPS 3Y11.23%

EPS 5Y

EPS Q2Q%

EPS Next Y-0.65%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)7.52%

Revenue growth 3Y2.52%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y